Immunovant, Inc. (IMVT)
Nasdaq: IMVT · CIK 0001764013 · United States
Every official Immunovant, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open IMVT filings
Immunovant, Inc. documents
- Immunovant, Inc. 10-K 2026IMVT 10-K 2026: annual report for fiscal 2026
- Immunovant, Inc. 10-K 2025IMVT 10-K 2025: annual report for fiscal 2025
- Immunovant, Inc. 10-K 2024IMVT 10-K 2024: annual report for fiscal 2024
- Immunovant, Inc. 10-K 2023IMVT 10-K 2023: annual report for fiscal 2023
- Immunovant, Inc. 10-K 2022IMVT 10-K 2022: annual report for fiscal 2022
- Immunovant, Inc. 10-Q 2026IMVT 10-Q 2026: quarterly report for fiscal 2026
- Immunovant, Inc. 10-Q 2025IMVT 10-Q 2025: quarterly report for fiscal 2025
- Immunovant, Inc. 10-Q 2024IMVT 10-Q 2024: quarterly report for fiscal 2024
- Immunovant, Inc. 10-Q 2023IMVT 10-Q 2023: quarterly report for fiscal 2023
- Immunovant, Inc. 10-Q 2022IMVT 10-Q 2022: quarterly report for fiscal 2022
- Immunovant, Inc. 8-K 2026IMVT 8-K 2026: current report for fiscal 2026
- Immunovant, Inc. 8-K 2025IMVT 8-K 2025: current report for fiscal 2025
- Immunovant, Inc. 8-K 2024IMVT 8-K 2024: current report for fiscal 2024
- Immunovant, Inc. 8-K 2023IMVT 8-K 2023: current report for fiscal 2023
- Immunovant, Inc. 8-K 2022IMVT 8-K 2022: current report for fiscal 2022
- Immunovant, Inc. DEF 14A 2026IMVT DEF 14A 2026: proxy statement for fiscal 2026
- Immunovant, Inc. DEF 14A 2025IMVT DEF 14A 2025: proxy statement for fiscal 2025
- Immunovant, Inc. DEF 14A 2024IMVT DEF 14A 2024: proxy statement for fiscal 2024
- Immunovant, Inc. DEF 14A 2023IMVT DEF 14A 2023: proxy statement for fiscal 2023
- Immunovant, Inc. DEF 14A 2022IMVT DEF 14A 2022: proxy statement for fiscal 2022
- Immunovant, Inc. Form 4 2026IMVT Form 4 2026: insider trading filing for fiscal 2026
- Immunovant, Inc. Form 4 2025IMVT Form 4 2025: insider trading filing for fiscal 2025
- Immunovant, Inc. Form 4 2024IMVT Form 4 2024: insider trading filing for fiscal 2024
- Immunovant, Inc. Form 4 2023IMVT Form 4 2023: insider trading filing for fiscal 2023
- Immunovant, Inc. Form 4 2022IMVT Form 4 2022: insider trading filing for fiscal 2022
- Immunovant, Inc. S-1 2026IMVT S-1 2026: registration statement for fiscal 2026
- Immunovant, Inc. S-1 2025IMVT S-1 2025: registration statement for fiscal 2025
- Immunovant, Inc. S-1 2024IMVT S-1 2024: registration statement for fiscal 2024
- Immunovant, Inc. S-1 2023IMVT S-1 2023: registration statement for fiscal 2023
- Immunovant, Inc. S-1 2022IMVT S-1 2022: registration statement for fiscal 2022
- Immunovant, Inc. 13F 2026IMVT 13F 2026: institutional holdings for fiscal 2026
- Immunovant, Inc. 13F 2025IMVT 13F 2025: institutional holdings for fiscal 2025
- Immunovant, Inc. 13F 2024IMVT 13F 2024: institutional holdings for fiscal 2024
- Immunovant, Inc. 13F 2023IMVT 13F 2023: institutional holdings for fiscal 2023
- Immunovant, Inc. 13F 2022IMVT 13F 2022: institutional holdings for fiscal 2022
More companies